Wonguen Jung1, Kyubo Kim1, Seog Ki Min2, Eun Mi Nam3, Jeong Kyong Lee4. 1. 1 Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Republic of Korea. 2. 2 Department of Surgery, Ewha Womans University College of Medicine, Seoul, Republic of Korea. 3. 3 Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea. 4. 4 Department of Radiology, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
Abstract
OBJECTIVE: To generate a map of local recurrences after pancreaticoduodenectomy (PD) for patients with distal extrahepatic cholangiocarcinoma (DEHC) and to evaluate the adequate target volume coverage encompassing the majority of local recurrences when the clinical target volume (CTV) for pancreatic cancer was applied. METHODS: We retrospectively reviewed the records of DEHC patients who underwent pancreaticoduodenectomy and had postoperative CT scans acquired between 1991 and 2015 available. The sites of local recurrence were delineated on individual CT scans, and then, mapping was manually performed onto template CT images. Coverage of each site of local recurrence was evaluated by applying the CTV defined according to Radiation Therapy Oncology Group (RTOG) consensus guidelines (CTVRTOG ) for target delineation in the postoperative treatment of pancreatic head cancer. RESULTS: Of the 99 patients, 36 patients had a total of 62 local relapses identifiable by postoperative CT scans; the relapses were the most frequent in the choledochojejunostomy (CJ) site, 11 sites (17.7%); para-aortic area, 10 sites (16.1%), superior mesenteric artery area, 10 sites (16.1%); and portal vein area, 9 sites (14.5%). 21 sites (33.9%) were not covered by the CTVRTOG, and the most common site of local recurrence outside the CTVRTOG was the CJ site. CONCLUSION: When mapping of local relapses was evaluated according to the CTVRTOG, the choledochojejunostomy site was identified as a high-risk area of local recurrence but was insufficiently covered within the CTVRTOG. These findings may help construct a target volume for postoperative radiotherapy in DEHC. ADVANCES IN KNOWLEDGE: Mapping local recurrences can aid in defining appropriate target volume for postoperative radiotherapy in DEHC.
OBJECTIVE: To generate a map of local recurrences after pancreaticoduodenectomy (PD) for patients with distal extrahepatic cholangiocarcinoma (DEHC) and to evaluate the adequate target volume coverage encompassing the majority of local recurrences when the clinical target volume (CTV) for pancreatic cancer was applied. METHODS: We retrospectively reviewed the records of DEHC patients who underwent pancreaticoduodenectomy and had postoperative CT scans acquired between 1991 and 2015 available. The sites of local recurrence were delineated on individual CT scans, and then, mapping was manually performed onto template CT images. Coverage of each site of local recurrence was evaluated by applying the CTV defined according to Radiation Therapy Oncology Group (RTOG) consensus guidelines (CTVRTOG ) for target delineation in the postoperative treatment of pancreatic head cancer. RESULTS: Of the 99 patients, 36 patients had a total of 62 local relapses identifiable by postoperative CT scans; the relapses were the most frequent in the choledochojejunostomy (CJ) site, 11 sites (17.7%); para-aortic area, 10 sites (16.1%), superior mesenteric artery area, 10 sites (16.1%); and portal vein area, 9 sites (14.5%). 21 sites (33.9%) were not covered by the CTVRTOG, and the most common site of local recurrence outside the CTVRTOG was the CJ site. CONCLUSION: When mapping of local relapses was evaluated according to the CTVRTOG, the choledochojejunostomy site was identified as a high-risk area of local recurrence but was insufficiently covered within the CTVRTOG. These findings may help construct a target volume for postoperative radiotherapy in DEHC. ADVANCES IN KNOWLEDGE: Mapping local recurrences can aid in defining appropriate target volume for postoperative radiotherapy in DEHC.
Authors: Tamara Z Vern-Gross; Anand T Shivnani; Ke Chen; Christopher M Lee; Jonathan D Tward; O Kenneth MacDonald; Christopher H Crane; Mark S Talamonti; Louis L Munoz; William Small Journal: Int J Radiat Oncol Biol Phys Date: 2010-10-23 Impact factor: 7.038
Authors: R Sasaki; M Takahashi; O Funato; H Nitta; M Murakami; H Kawamura; T Suto; S Kanno; K Saito Journal: Surgery Date: 2001-06 Impact factor: 3.982
Authors: A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron Journal: Ann Surg Date: 1996-10 Impact factor: 12.969
Authors: Avani S Dholakia; Rachit Kumar; Siva P Raman; Joseph A Moore; Susannah Ellsworth; Todd McNutt; Daniel A Laheru; Elizabeth Jaffee; John L Cameron; Phuoc T Tran; Robert F Hobbs; Christopher L Wolfgang; Joseph M Herman Journal: Int J Radiat Oncol Biol Phys Date: 2013-12-01 Impact factor: 7.038
Authors: Rosa B Schmuck; Cynthia V de Carvalho-Fischer; Christopher Neumann; Johann Pratschke; Marcus Bahra Journal: Cancer Med Date: 2015-12-09 Impact factor: 4.452
Authors: Seo Hee Choi; Chai Hong Rim; In-Soo Shin; Won Sup Yoon; Woong Sub Koom; Jinsil Seong Journal: Liver Cancer Date: 2021-08-26 Impact factor: 11.740